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Conclusion. We conclude that gentamicin inhibits Na/PiGentamicin causes endocytosis of Na/Pi cotransporter protein
cotransport activity by causing a decrease in the expression of(NaPi-2).
the type II Na/Pi cotransport protein at the level of the proxi-Background. Renal toxicity is a major side-effect of amino-
mal tubular apical BBM and that inhibition of Na/Pi cotrans-glycoside antibiotics and is characterized by an early impair-
port activity is most likely mediated by post-transcriptionalment in proximal tubular function. In a previous study, we
mechanisms.have shown that gentamicin administration to the rat causes
an early impairment in sodium gradient-dependent phosphate
(Na/Pi) cotransport activity. The purpose of our current study
was to determine the molecular mechanisms of the impairment Proximal tubular dysfunction is a central feature ofin Na/Pi cotransport activity, specifically the role of the proxi-
aminoglycoside nephrotoxicity. In humans and in exper-mal tubular type II Na/Pi cotransporter.
imental animals treated with aminoglycoside antibiot-Methods. Rats were treated for one, two, and three days
with two daily injections of 30 mg/kg body weight gentamicin ics, the increase in the urinary excretion of glucose, amino
or the vehicle. acids, and luminal brush-border membrane (BBM)-bound
Results. Gentamicin caused a progressive decrease in super- enzymes occurs before a reduction in glomerular filtrationficial cortical apical brush-border membrane (SC-BBM) Na/Pi
rate (GFR) [1–4]. We have previously shown that treat-cotransporter activity (856 6 93 in control vs. 545 6 87 pmol/mg
ment of rats with gentamicin results in an early decreaseBBM protein in 3-day gentamicin, P , 0.01). Western blot
analysis showed a parallel and progressive decrease in SC- in proximal tubular luminal BBM sodium gradient-
BBM Na/Pi cotransporter protein abundance, a 50% decrease dependent phosphate transport (Na/Pi cotransport) and
after one day of treatment, a 63% decrease after two days of
pH gradient-dependent sodium transport (Na/H ex-treatment, and an 83% decrease after three days treatment with
change) activities, prior to a reduction in GFR [5].gentamicin. In contrast, gentamicin treatment had no effect
on Na/Pi cotransport activity or Na/Pi cotransporter protein The purpose of the present study was to characterize
abundance in BBM isolated from the juxtamedullary cortex the cellular and molecular mechanisms involved in the
(JMC-BBM). Immunofluorescence microscopy showed a ma- gentamicin-induced decrease in renal proximal tubular
jor decrease in the expression of Na/Pi cotransporter protein
phosphate transport and specifically to determine a rolein the apical membrane of the proximal convoluted tubule,
for the type II Na/Pi cotransport (NaPi-2) protein andwith progressive intracellular accumulation of Na/Pi protein.
Colocalization studies showed that in gentamicin-treated rats, mRNA in this process.
Na/Pi protein was colocalized in the early endosomes and espe- Our results indicate that treatment of rats with genta-
cially in the lysosomes. Northern blot analysis of cortical RNA micin causes a progressive decrease in superficial cortical
interestingly showed no reduction in Na/Pi cotransporter mRNA
(SC-BBM) but not juxtamedullary cortical (JMC-BBM)abundance even after three days of gentamicin treatment.
Na/Pi cotransport activity, which is associated with a
progressive decrease in SC-BBM NaPi-2 protein abun-
1 Drs. Sorribas and Halaihel contributed equally to this study. dance but not NaPi-2 mRNA abundance. Furthermore,
gentamicin causes a progressive translocation of NaPi-2Key words: early endosomes, lysosomes, axial hetergeneity, phospha-
protein from the apical BBM to the late endosomal/tidylinositol, renal toxicity, type II Na/Pi cotransport activity, nephro-
toxicity. lysosomal compartment. Our results therefore suggest
that gentamicin causes a progressive decrease in Na/PiReceived for publication June 9, 2000
cotransport activity by post-transcriptional mechanisms,and in revised form September 22, 2000
Accepted for publication September 28, 2000 most likely involving the progressive endocytosis of
NaPi-2 protein from the apical BBM.Ó 2001 by the International Society of Nephrology
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METHODS Enzyme activity measurements
The activities of maltase (a marker of proximal convo-Study groups
luted tubule BBM) and g-glutamyl transferase (a markerStudies were performed on male Sprague-Dawley rats
of proximal straight tubule BBM) were measured as pre-(Charles River Laboratories, Kingston, NY, USA). The
viously described [5, 6] in SC and JMC homogenatesrats were virus antibody titer-free and weighed between
and SC and JMC BBM to determine the purity of BBM225 and 250 g. Experiments were started after animals
isolated from control and gentamicin-treated rats.were adapted on a control diet (0.6% Ca, 0.6% Pi, Teklad)
for seven days. The animals then received gentamicin Brush-border membrane transport
sulfate, 30 mg/kg body weight, administered subcutane- activity measurements
ously twice a day, or vehicle (0.9% NaCl) for a one-,
Brush-border membrane Na/Pi cotransport activitytwo-, or three-day period. At the end of the treatment
measurements were performed in freshly isolated BBMperiod, eight rats in each experimental group were anes-
vesicles by the radiotracer uptake of 100 mmol/L K2H32PO4thetized with intraperitoneal pentobarbital. The kidneys
(Dupont-NEN Research Products, Boston, MA, USA)were then rapidly removed; one half of one kidney was
and an inwardly directed sodium gradient (150 mmol/Lused for RNA isolation, and the other three halves were
NaCl) followed by rapid filtration [8]. Uptake was ter-used for BBM isolation. In additional experiments, four
minated after 10 seconds, representing the initial linear
rats in each experimental group were anesthetized and
rate. Na/glucose and Na/proline cotransport measure-
perfused in vivo for immunofluorescence microscopy for
ments were also performed in a similar manner by radio-
NaPi-2 protein, as described later in this article. tracer uptake of [3H]-d-glucose or [3H]-l-proline (Du-
pont-NEN), respectively.Isolation of cortical homogenate and
brush-border membranes Brush border membrane SDS-gel protein
Thin slices from the rat kidney SC and JMC were cut electrophoresis and Western blot analysis
at 48C and homogenized with a Polytron homogenizer Brush border membranes were denatured for two min-
in a buffer consisting of 300 mmol/L mannitol, 5 mmol/L utes at 958C in 2% sodium dodecyl sulfate (SDS), 10%
ethylene glycol-bis (-aminoethyl ether) -N, N, N· N·- glycerol, 0.5 mmol/L ethylenediaminetetraacetic acid
tetraacetic acid, 1 mmol/L phenylmethylsulfonyl fluoride, (EDTA), 95 mmol/L Tris-HCl, pH 6.8 (final concentra-
16 mmol/L N-2-hydroxyethylpiperazine-N· -2 ethane- tions). Ten micrograms of BBM protein/lane were sepa-
sulfonic acid (HEPES), and 10 mmol/L Tris (hydroxy- rated on 9% polyacrylamide gels according to the
methyl) aminomethane (Tris), pH 7.50. Aliquots were method of Laemmli [9] and then electrotransferred onto
saved for (1) enzyme activity measurement, (2) Western nitrocellulose paper [10]. After blockage with 5% nonfat
blotting, and (3) measurement of gentamicin content. milk powder with 1% Triton X-100 in Tris-buffered sa-
From the resulting SC and JMC homogenates, apical line (20 mmol/L, pH 7.3), Western blots were performed
BBM vesicles were prepared by differential centrifuga- with antiserum against the C-terminal amino acid se-
tion after Mg21 aggregation as previously described [6]. quence of NaPi-2 at a dilution of 1:5000. Primary anti-
Briefly, to each 15 mL of homogenate in isolation buffer, body binding was visualized using enhanced chemilumi-
0.54 mL of 1.0 mol/L MgCl2 in 21 mL of water was nescence (Pierce, Bradford, IL, USA), and the signals
added. After 20 minutes of shaking, the homogenate were quantitated in a Phosphor Imager with chemilumi-
was centrifuged at 2790 3 g for 15 minutes. The pellet nescence detector and densitometry software (Bio-Rad,
resulting from the first Mg precipitation step was saved Richmond, CA, USA). The protein blots were also
and labeled as non-BBM membranes, and an aliquot probed with antiserum against b-actin (Sigma).
was saved for Western blotting. The supernatant was
Measurement of brush-border membranesubjected to another round of Mg precipitation, and the
lipid compositionresultant supernatant was centrifuged at 40,000 3 g for
30 minutes. The resulting pellet corresponding to BBM Lipids from BBMs were extracted by the method of
was resuspended in a buffer of 300 mmol/L mannitol, Bligh and Dyer [11]. To determine individual phospho-
16 mmol/L HEPES, and 10 mmol/L Tris, pH 7.50, and lipid polar head group species, an aliquot of the lipid
was aliquoted for simultaneous measurements of (1) en- extract was applied to thin-layer chromatography plates
zyme activity, (2) transport activity, (3) protein electro- (Silica Gel 60; E. Merck, Darmstadt, Germany). Individ-
phoresis and Western blotting, (4) lipid composition, ual phospholipids, including sphingomyelin, phosphatidyl-
and (5) gentamicin binding. Protein concentrations of the choline, phosphatidylethanolamine, phosphatidylserine,
cortical homogenate, non-BBM, and BBM fractions were and phosphatidylinositol, were separated by two-dimen-
sional thin layer chromatography (TLC) [12]. Phospho-determined by the method of Lowry et al [7].
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Table 1. Effects of three days of gentamicin administration on BBM
enzyme activity
Control Gentamicin P value
Superficial cortex
Maltase
CH 16.560.7 16.961.1 NS
BBM 183.8619.0 177.266.1 NS
Enrichment 11.160.9 10.560.4 NS
Recovery 32.062.6 30.260.4 NS
g-Glutamyl transferase
CH 120.165.7 123.666.1 NS
BBM 1627.1678.1 1705.7683.4 NS
Enrichment 13.661.0 13.861.2 NS
Recovery 39.262.9 39.863.4 NS
Justamedullary cortex
Maltase
CH 9.960.6 10.160.8 NS
BBM 107.9610.4 112.1612.1 NS
Enrichment 10.960.7 11.160.8 NS
Recovery 31.462.3 32.062.9 NS
g-Glutamyl transferase
CH 258.7611.8 255.9612.6 NS
BBM 3621.86173.8 3531.46184.9 NS
Enrichment 14.061.2 13.861.8 NS
Recovery 40.363.4 39.863.1 NS
Values are means 6 SE; N 5 12 rats in each group. Abbreviations are:
CH, cortical homogenate; BBM, brush-border membrane. Enzyme activity is
expressed as micromoles per hour per milligram CH or BBM protein. Enrichment
is defined as the ratio of specific activity in BBM fraction/specific activity in
homogenate. Recovery (%) is defined as the ratio of total activity in BBM
fraction/total activity in homogenate.
capacity) and Kd (binding affinity) were calculated by
Fig. 1. Effect of gentamicin on sodium gradient-dependent phosphate Scatchard plot.
(Na/Pi) cotransport activity in (A) superficial cortical brush-border
membranes (SC-BBM) and (B) juxtamedullary cortical brush-border
RNA isolation, formaldehyde gel electrophoresis, andmembranes (JMC-BBM). NA/Pi cotransport activity was determined
by sodium gradient-dependent uptake of 32Pi into BBM vesicles. Genta- Northern blot analysis
micin caused a progressive decrease in SC-BBM but not JMC-BBM
Thin slices from kidney superficial cortex were cut onNa/Pi transport activity. The results are presented as mean SEM. N 5
6 in each group. an ice-cold glass dish and homogenized with a Polytron
homogenizer in a denaturazation solution containing 4
mol/L guanidium thiocyanate, 25 mmol/L sodium citrate,
pH 7.0, 0.5% sarcosyl, and 0.1 mol/L of 2-mercaptoetha-
lipid content of total and individual phospholipids was nol. Sequentially, 0.1 volumes of 2 mol/L sodium acetate,
determined by measuring phosphorus content by the pH 4.0, 1 volume water-saturated phenol, and 0.2 vol-
method of Ames and Dubin [13]. umes chloroform-isoamyl alcohol mixture (49:1) were
added to the homogenate. Total RNA was isolated as
Cortical homogenate gentamicin content measurement previously described [8, 15, 16], and 10 mg of each sample
Gentamicin content of SC and JMC homogenate sam- were size fractionated by agarose-formaldehyde gel
ples obtained from gentamicin-treated rats was mea- electrophoresis and transferred to nylon membranes by
sured by radioimmunoassay (Rainen gentamicin RIA a vacuum-blotting device (Bio-Rad). Prehybridization
kit; DuPont, Billerica, MA, USA) [14]. (4 hours at 428C) and hybridization (18 h at 428C) of the
RNA blots were performed with a buffer consisting of
Brush-border membrane 5 3 SSPE (0.75 mol/L NaCl, 50 mmol/L NaH2PO4,
gentamicin-binding measurements 5 mmol/L EDTA, pH 7.40), 5 3 Denhardt’s solution
Binding of [3H]-gentamicin to SC-BBM and JMC- [0.1% Ficoll 400, 0.1% polyvinylpyrrolidone, and 0.1%
BBM isolated from control (that is, nongentamicin bovine serum (albumin fraction V)], 0.1% SDS, 100
treated) rats was performed at 48C. Specific binding was mg/mL denatured salmon sperm DNA, and 50% deion-
calculated as the difference between total gentamicin ized formamide [8, 16, 17]. A full-length cDNA probe
binding and nonspecific binding in the presence of 100- of NaPi-2 [18] was labeled by random hexamer priming
(Pharmacia) using [8-32P] dCTP (Dupont-NEN). Blotsfold excess nonradioactive gentamicin. Bmax (binding
Sorribas et al: Gentamicin and NaPi-2 1027
Fig. 2. Effect of gentamicin on NaPi-2 protein abundance, as determined by Western blotting in (A) SC-BBM, (B) SC homogenate, (C ) SC other,
non-BBMs, and (D) JMC-BBM. Gentamicin caused a progressive decrease in SC-BBM NaPi-2 protein abundance, no change in SC-homogenate
(that is, total) NaPi-2 protein abundance, and a reciprocal increase in SC other membrane (that is, non-BBM) NaPi-2 protein abundance. In
contrast, gentamicin had no effect on JMC-BBM NaPi-2 protein abundance. The results are presented as mean 6 SEM. N 5 6 in each group.
were washed twice for 15 minutes in 0.1 3 SSPE with
0.1% SDS at 378C and twice for 15 minutes each time
in 0.1 3 SSPE with 0.1% SDS at 508C. Hybridization
signals were quantitated by a phosphor imager analyzing
system (BioRad, Richmond, CA, USA) and normalized
for loading using full-length rat glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) [19] and 18S rRNA
oligonucleotide probes synthesized as described [20].
Immunofluorescence microscopy
Rats were anesthetized with thiopental (Penthotal, 100
mg/kg body weight) and perfused retrograde at a pres-
sure of 1.38 hp through the abdominal aorta. The fixative
consisted of 3% paraformaldehyde and 0.05% picric acid
in a 6:4 mixture of cacodylate buffer (pH 7.4, adjusted to
300 mosmol with sucrose) and 10% hydroxyethyl starch.
After five minutes of fixation, the rats were perfused for
Fig. 3. Effect of gentamicin on NaPi-2 mRNA abundance, as deter-an additional five minutes with the cacodylate buffer [21].
mined by Northern blotting, in SC. Gentamicin caused no changes in
Coronal slices of fixed kidneys were snap frozen in NAPi-2 mRNA abundance. The results are presented as mean 6 SEM.
N 5 6 in each group.liquid propane cooled by liquid nitrogen. Sections 3 mm
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Fig. 4. Effect of gentamicin on proximal tubular expression of NaPi-2 (fluorescein, green), as determined by immunofluorescence microscopy.
Gentamicin caused a progressive decrease in proximal tubular apical brush-border membrane NaPi-2 protein abundance, while causing a progressive
increase in intracellular NaPi-2 accumulation. The results are representative of four different rats studied in each group.
thick were cut at 2228C in the cryomicrotome, mounted NaPi-2 antibody [22] diluted 1:500 in the preincubation
solution. The sections were rinsed three times with PBSon chromalum/gelatin-coated glass slides, thawed, and
stored in cold phosphate-buffered saline (PBS) buffer prior to incubation for one hour at 48C with the second-
ary antibody, swine anti-rabbit IgG conjugated to FITCuntil use.
For NaPi-2 immunofluorescence staining, sections (Dakopatts, Glostrup, Denmark).
To perform NaPi-2/early endosome (EEA-1) andwere preincubated for five minutes at room temperature
with 3% milk powder in PBS containing 0.05% Triton NaPi-2/lysosome (lgp-120) double immunofluorescence
staining, the sections were covered overnight with theX-100. They were then covered overnight at 48C with the
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Fig. 5. Effect of gentamicin on proximal tubular expression of (a) NaPi-2 and (b) EEA-1, an early endosome marker protein, as determined by
immunofluorescence microscopy. Following treatment with gentamicin, apical membrane NaPi-2 expression is decreased, while there is increased
colocalization with EEA-1.
antibody against NaPi-2 protein at 1:500 dilution, and tests was used to compare results between control and
either a mouse monoclonal antibody against early endo- gentamicin-treated rats. Significance was accepted at
somal antigen (EEA-1, Transduction Labs, Lexington, P , 0.05.
KY, USA) at 1:500 dilution [23], or a mouse anti-rat
antibody against the lysosomal membrane glycoprotein
RESULTSlgp-120 at 1:200 dilution [24], in PBS/milk powder.
After rinsing with PBS, the sections were mounted us- Gentamicin causes a progressive decrease in
ing Dako-Glycergele (Dakopatts) plus 2.5% 1,4-diaza- superficial cortical brush-border membrane
bicyclo-[2.2.2] octane (DABCO; Sigma, St. Louis, MO, Na/Pi cotransport activity
USA) as a fading retardant. They were then imaged
Compared with vehicle-treated control rats, gentami-with a laser scanning microscope (Zeiss LSM 410, Jana,
cin treatment for one, two, and three days caused a sig-Germany) by confocal fluorescence imaging.
nificant and progressive decrease in Na/Pi cotransport
Statistical analysis activity in BBM vesicles isolated from the superficial
cortex (SC-BBM; Fig. 1A). In contrast, as we have pre-Data are expressed as mean 6 SE. A one-way analysis
of variance with Student-Newman-Keul’s multiple range viously shown [5], gentamicin treatment had no effect on
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Fig. 6. Effect of gentamicin on proximal tubular expression of (a) NaPi-2 and (b) lgp-120, a lysosomal marker protein, as determined by
immunofluorescence microscopy. Following treatment with gentamicin, apical membrane NaPi-2 expression is decreased, while there is no change
in the expression of lgp-120.
SC-BBM Na/glucose or Na/proline cotransport activities BBM NaPi-2 protein abundance (Fig. 2A). Interestingly,
(results not shown). The differences in BBM Na/Pi co- gentamicin had no significant effect on superficial corti-
transport activity were not due to differences in the pu- cal homogenate (total) NaPi-2 protein abundance (Fig.
rity of the BBM isolated from control versus gentamicin- 2B), while gentamicin caused a significant and progres-
treated rats, as the enrichment for the BBM enzyme sive increase in superficial cortical non-BBM NaPi-2 pro-
markers maltase and g-glutamyl transferase were identi- tein abundance (Fig. 2C). This suggests that gentamicin
cal in the two groups (Table 1).
causes translocation of NaPi-2 protein from the apical
BBM to inside the cell and contained in an intracellular
compartment in which they are not degraded, as thereGentamicin causes a progressive decrease in
was no change in total NaPi-2 protein abundance, evensuperficial cortical brush-border membrane
NaPi-2 protein abundance after three days of treatment with gentamicin. In contrast
to the effect on SC-BBM NaPi-2 protein abundance,The effect of gentamicin on SC-BBM Na/Pi cotrans-
gentamicin had no effect on b-actin protein abundanceport activity was paralleled by a similar effect of gentami-
cin to cause a progressive decrease in superficial cortical (results not shown).
Sorribas et al: Gentamicin and NaPi-2 1031
Fig. 7. (A) Effect of gentamicin on proximal tubular expression of NaPi-2 (fluorescein, green) and EEA-1 (rhodamine, red), an early endosome
marker protein, as determined by immunofluorescence microscopy. Following treatment with gentamicin, apical membrane NaPi-2 expression is
decreased, while there is increased co-localization with EEA-1 (yellow color), suggesting accumulation of NaPi-2 in an early endosomal compartment.
(B) Effect of gentamicin on proximal tubular expression of NaPi-1 (fluorescein, green) and lgp-120 (rhodamine, red), a lysosomal marker protein,
as determined by immunofluorescence microscopy. Following treatment with gentamicin, apical membrane NaPi-2 is decreased, while there is
increased co-localization with lgh-120 (yellow color), suggesting accumulation of NaPi-2 in lysosomes.
Gentamicin does not cause a decrease in superficial caused a progressive decrease in NaPi-2 specific immu-
cortical NaPi-2 mRNA abundance nostaining in apical luminal membranes of the proximal
convoluted tubule (Fig. 4). The decrease in luminal mem-In spite of the effect of gentamicin to cause a progres-
brane immunostaining was associated with a progressivesive decrease in superficial cortical BBM Na/Pi cotrans-
increase in intracellular staining (Fig. 4).port activity and BBM NaPi-2 protein abundance, genta-
Additional immunofluorescence studies were per-micin had no effect on superficial cortical NaPi-2 mRNA
formed to determine the intracellular compartment inabundance (Fig. 3). This suggests that the effect of genta-
which the NaPi-2 immunostaining was localized, includ-micin to inhibit Na/Pi cotransport activity is mediated
ing the early endosomal compartment (Fig. 5) and lyso-by post-transcriptional mechanisms.
somes (Fig. 6). The co-localization studies using immu-
Gentamicin causes enhanced internalization of nofluorescence microscopy revealed that gentamicin
Na/Pi cotransport protein to endosomal and initially caused translocation of NaPi-2 protein from the
lysosomal compartments apical BBM to the early endosomal compartment, as
evidenced by significant co-localization (yellow; Fig. 7A)Similar to the Western blot results (Fig. 2A), immuno-
fluorescence microscopy also revealed that gentamicin of NaPi-2 immunostaining (green) with early endosomal
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in JMC-BBM PI content (Fig. 10A). The increase in PI
content would result in further enhancement of gentami-
cin binding to SC-BBM and result in increased gentamicin
accumulation in the superficial cortex (Fig. 8).
In agreement with our earlier results [5], gentamicin
also caused a significant decrease in SC-BBM sphingo-
myelin, an increase in phosphatidylcholine, and a de-
crease in sphingomyelin to phosphatidylcholine mole ra-
tio (Fig. 10B). In contrast, gentamicin had no significant
effects in sphingomyelin and phosphatidylcholine con-
tent in JMC-BBM (Fig. 10B).
DISCUSSION
We have previously shown that treatment of rats with
gentamicin causes an early decrease in proximal tubular
apical BBM Na/Pi cotransport activity, prior to a reduction
in GFR [5]. In the present study, we have determined thatFig. 8. Effect of gentamicin treatment on gentamicin levels in SC (h)
and JMC (j) homogenates, as determined by radioimmunoassay. the decrease in BBM Na/Pi cotransport activity is medi-
Treatment with gentamicin causes significantly higher gentamicin levels ated by a decrease in BBM NaPi-2 protein expression.in SC homogenate compared with JMC homogenate. The results are
One interesting and intriguing finding of our study isexpressed as mean 6 SEM. N 5 6 in each group.
that the decrease in BBM NaPi-2 protein occurs indepen-
dent of a decrease in NaPi-2 mRNA. In previous studies,
we have shown that acute regulation of NaPi-2 by alter-
ations in dietary phosphate [8, 21], parathyroid hormone
antigen EEA-1 immunostaining (red). There was also [25, 26], and metabolic acidosis [22] can indeed occur
evidence of progressively strong co-localization (yellow; prior to changes in NaPi-2 mRNA. However, usually
Fig. 7B) of NaPi-2 immunostaining (green) with lyso- after six hours of the experimental perturbation, there
somal immunostaining (red). is a parallel change in NaPi-2 mRNA as well. Interest-
ingly, in this study, even after three days of gentamicinGentamicin has no effect on juxtamedullary cortical
administration, there is no change in NaPi-2 mRNA lev-
brush-border membrane Na/Pi cotransport activity
els. This suggests that gentamicin modulates NaPi-2 pro-
In contrast to the inhibitory effect of gentamicin on tein expression by post-transcriptional mechanisms that
SC-BBM Na/Pi cotransport activity, gentamicin was are independent of changes in mRNA.
without an inhibitory effect on JMC-BBM Na/Pi cotrans- Another interesting and intriguing finding of our study
port activity (Fig. 1B). In agreement with the lack of is that although gentamicin causes a progressive decrease
inhibitory effect of gentamicin on JMC-BBM Na/Pi co- in the expression of apical membrane NaPi-2 protein,
transport activity, gentamicin had no effect on JMC- the NaPi-2 protein accumulates in an intracellular com-
BBM NaPi-2 protein abundance (Fig. 2D). partment and is not degraded. In fact, even after three
To determine the potential mechanisms for the differ- days of treatment with gentamicin, the level of total kid-
ential effect of gentamicin on SC and JMC-BBM Na/Pi ney (that is, cortical homogenate) NaPi-2 protein is not
transport activity, we measured gentamicin levels in SC altered. Therefore, following gentamicin administration
and JMC homogenates. Gentamicin levels were much NaPi-2 is endocytosed and accumulates in an intracellu-
higher in SC homogenate compared with JMC homoge- lar compartment, most likely the lysosomes. Following
nate (Fig. 8). BBM gentamicin-binding studies indicated treatment with a high Pi diet [8, 21] and/or parathyroid
that this was associated with increased binding of genta- hormone (PTH) [25, 26], NaPi-2 is also endocytosed from
micin to SC-BBM compared with JMC-BBM (Fig. 9). the apical BBM and is eventually accumulated in the
Finally, since gentamicin binding to BBM is enhanced lysosomes where it is degraded. In the case of gentamicin,
by negatively charged phospholipids, including phospha- however, gentamicin is rapidly targeted to the lysosomes
tidylinositol (PI), we measured PI content in SC- and [14, 27–31] and is an inhibitor of lysosomal enzymes
JMC-BBM. We found that PI levels are markedly higher [32–38], and therefore, the NaPi-2 protein is accumulated
in SC-BBM (Fig. 10). In addition, following treatment in the lysosomes without degradation. A similar picture
with gentamicin, there is a further significant increase in is seen when rats are first pretreated with leupeptin, an
inhibitor of lysosomal enzymes, and then the rats areSC-BBM PI content, while there is no significant alteration
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Fig. 9. Gentamicin binding to SC-BBM and
JMC-BBM in BBM isolated from control, that
is, nongentamicin treated rats, as determined
by Scatchard plot. Symbols are: (h) control;
(j) gentamicin. Bmax (binding capacity) is sig-
nificantly higher in SC-BBM compared with
JMC-BBM. The results are expressed as
mean 6 SEM. N 5 6 in each group.
fed a high Pi diet and/or infused with PTH, in which the creases in membrane fluidity would enhance the activity
internalized NaPi-2 protein is localized in the lysosomes of the Na/Pi cotransporter proteins [16, 43, 44], the in-
[21, 26, 39]. crease in SC-BBM lipid fluidity may in part explain the
Gentamicin interestingly has differential effects on Na/Pi leveling of the decrease in SC-BBM Na/Pi cotransport
cotransport activity and NaPi-2 protein abundance in activity in spite of a further progressive decrease in SC-
SC-BBM versus JMC-BBM. Gentamicin causes a pro- BBM NaPi-2 protein abundance.
gressive decrease in SC-BBM Na/Pi cotransport activity Megalin or glycoprotein 330 [45] plays an important
and NaPi-2 protein abundance, whereas it has no effect role in binding and internalizing gentamicin in the renal
on JMC-BBM Na/Pi cotransport activity or NaPi-2 pro- proximal tubule [46, 47]. In addition, megalin has also
tein abundance. The differential effects of gentamicin been shown to play an important role in the gentamicin-
are associated with differential accumulation of gentami- induced inhibition of rat renal homotypic endosomal
cin in SC versus JMC homogenate. We propose that differ- fusion [48]. Megalin has also been shown to mediate the
ential gentamicin accumulation in SC versus JMC is most endocytosis of albumin in the proximal tubule [49] and
likely mediated by an increased capacity of SC-BBM to to be associated with the Na/H exchanger isoform NHE3
bind gentamicin, which is mediated by increased PI levels
in the proximal tubule [50]. Therefore, megalin may play
in SC-BBM, which is further increased after treatment
a role in gentamicin-induced internalization of NaPi-2.
with gentamicin. Previous studies have indeed shown
However, the studies by Biemesderfer et al [50] andthat gentamicin preferentially binds to anionic phospho-
preliminary studies in our laboratory have not shown anlipids, including PI [40–42], and the higher PI levels in
association between megalin and NaPi-2 in the proximalSC-BBM are compatible with increased gentamicin bind-
tubule. Thus, a role for megalin in mediating the effectsing to this segment of the proximal tubule. In addition
of gentamicin on NaPi-2 trafficking remains unknown.to Na/Pi cotransport activity, differential effects of genta-
In summary, our study indicates that gentamicin causesmicin on SC versus JMC are also demonstrated by the fact
a progressive decrease in SC-BBM Na/Pi cotransport ac-that gentamicin causes a decrease in sphingomyelin and
tivity and NaPi-2 protein abundance by post-translationalan increase in phosphatidylcholine in SC-BBM but not in
mechanisms. The effect of gentamicin to preferentiallyJMC-BBM. The effects of gentamicin on SC-BBM lipid
inhibit SC-BBM rather than JMC-BBM is associated withcomposition are in agreement with our earlier study [5].
increased gentamicin binding to SC-BBM and accumula-Interestingly, the gentamicin-induced decrease in sphin-
tion in SC-homogenate, due to increased levels of thegomyelin to phosphatidylcholine mole ratio is associated
with an increase in SC-BBM lipid fluidity [5]. Since in- negatively charged phosphatidylinositol in SC-BBM.
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Fig. 10. Lipid composition of SC-BBM and
JMC-BBM in vehicle (h) or gentamicin
treated (j) rats. (A) Phosphatidylinositol (PI)
levels are higher in SC-BBM compared with
JMC-BBM. Furthermore, treatment with gen-
tamicin causes a further increase in SC-BBM
PI content. (B) Gentamicin causes a decrease
in sphingomyelin (SM) and an increase in pho-
sphatidylcholine (PC) levels in SC-BBM but
not in JMC-BBM. The results are expressed
as mean 6 SEM. N 5 6 in each group.
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